First Wave BioPharma Announces Poster Presentation at the 2022 Digestive Disease Week (DDW) Conference
Poster presentation to feature research involving niclosamide as a potential treatment for mild-to-moderate ulcerative proctitis…
News
BioCryst to Present at Upcoming Investor Conferences
RESEARCH TRIANGLE PARK, N.C., March 03, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today…
TELA Bio Announces U.S. Commercial Launch of SiteGuard™ No Rinse Antimicrobial Solution
Company expands product portfolio with focus on addressing surgical site infections in plastic reconstructive surgery…
Medicenna Announces Appointment of Clinical Advisory Board and Dr. Kapil Dhingra as Strategic Advisor
Medicenna’s Clinical Advisory Board is comprised of thought leaders in immuno-oncology with experience in clinical…
Antares Pharma Reports Fourth Quarter and Full-Year 2021 Financial and Operating Results
Full-Year 2021 Revenue Increased 23% Year-Over-Year to $184.0 Million Full-Year 2021 Net Income of $46.3…
Tilray Brands Announces Proposed Agreement for Strategic Alliance With Hexo Corp.
Tilray to Acquire Hexo Corp.’s Senior Secured Convertible Notes Commercial and financial alliance would bring…
Tonix Pharmaceuticals Announces FDA Orphan-Drug Designation for TNX-2900 for the Treatment of Prader-Willi Syndrome
CHATHAM, N.J., March 03, 2022 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix…
AnPac Bio’s Bio-Chip Subsidiary, Changwei System Technology Co., Ltd., Receives Independent Valuation and Approval from the Board to Explore Strategic Alternatives
PHILADELPHIA, March 03, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the…
Fulcrum Therapeutics® Announces REACH, a Phase 3 Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)
Reachable Workspace (RWS) primary endpoint based on discussions with FDA and EU regulatory agencies Trial…
Pardes Biosciences to Present at Cowen Healthcare Conference
CARLSBAD, Calif., March 03, 2022 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage…
Interim Results for the six months ended 31 December 2021
Allergy Therapeutics plc(“Allergy Therapeutics” or the “Company” or the “Group”) Interim Results for the six…
EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Highlights Recent Corporate Developments
– Positive EYP-1901 DAVIO Phase 1 eight-month data was presented at Angiogenesis, Exudation, and Degeneration…
Immunocore Reports Full Year 2021 Financial Results and Provides Business Update
PRESS RELEASE Immunocore Reports Full Year 2021 Financial Results and Provides Business Update KIMMTRAK® (tebentafusp-tebn)…
Orchard Therapeutics to Present at Multiple Investor Conferences in March 2022
BOSTON and LONDON, March 03, 2022 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global…
Mindset Pharma to Participate in Upcoming Investor Conferences in March 2022
TORONTO, March 03, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
HUTCHMED Reports 2021 Full Year Results and Provides Business Updates
Oncology/Immunology revenues up 296% to $119.6 million, due to ELUNATE® growth and the 2021 launches…
OXURION SUCCESSFULLY RAISES EUR >10 MILLION FROM LEADING US AND EUROPEAN HEALTHCARE INVESTORS IN A PRIVATE EQUITY PLACEMENT
Leuven, BELGIUM, Boston, MA, US – MARCH 3, 2022 – 08:00 AM CET – Oxurion…
Clover to Participate at Upcoming Investor Conferences
CHENGDU, China, March 03, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a…
ProntoForms Releases Customer Impact Report Demonstrating Powerful ROI
The report gathers key quantifiable business impacts experienced by customers OTTAWA, March 03, 2022 (GLOBE…
Polkadot Decoded 2022: 4 Locations, 3 Continents, 2 Days in June, 1 Awesome Experience
Zug, Switzerland–(Newsfile Corp. – March 3, 2022) – Polkadot is excited to announce plans to…